AAvamed Synergy — Seed (estimated) · €500K
Alicante-based deeptech Avamed Synergy closed the first phase of its first investment round at €800,000 to advance Fluxus, an AI-based precision-medicine platform for oncological imaging and tumour characterisation. A group of private investors contributed €500,000 and ENISA added the remaining €300,000; no lead investor was named.
Lead not disclosed
RoundSeed (estimated)
Announced8 Jan 2024
CityAlicante
SectorHealthtech & Bio · Healthtech
Source
A
A
The company
Investors 1
U
Undisclosed private investors